There are over 60+ upcoming IPOs over the next one month. Brief details on each company in thread🧵below.
Retweet ones you are excited about! Comment for more details.
1/n 👇
1. Paradeep Phosphates
#⃣ 3rd largest private sector maker & distributor of non-urea fertilizers in India
#⃣ 2nd largest in DAP volume sales as of Mar'21
#⃣ Key brand: ‘Jai Kisaan - Navratna’
#⃣ 80.5% S/H with a JV of Zuari Agro
#⃣ Issue size: ₹ 1,255 cr
#⃣ Financials below
#⃣ Speciality chemicals maker
#⃣ Products: 1. Additives used in skin & hair care products by FMCGs (among Top 2 globally) 2. APIs for anti-hypertension drugs 3. UV absorber ingredients
#⃣ Largest private health insurer and largest retail health insurance company in India
#⃣ Covers 2.05 cr lives via health ins. in FY21
#⃣ Retail: Group Health = 89%:11%
#⃣ GWP of ₹9,349 cr in FY21
#⃣ Investors: Westbridge, RJ
#⃣ Financials 👇
5. Ruchi Soya (FPO)
#⃣ Highlights: 1. Largest integrated palm oil refining co. in India 2. #1 in soya foods (Nutrela) 3. Acquired ‘Patanjali’ pf. of packaged foods (biscuits, noodles & cereals) 4. Entered Neutraceuticals in FY22
#⃣ Issue: ₹ 4,300 cr (FPO)
#⃣ Financials below
6. Nykaa
#⃣ Fastest growing beauty, personal care (BPC) and fashion products platform in India
#⃣BPC market size: ₹10 TN+ by FY25
#⃣ Inventory led model + own private label brands + omni-channel sales
#⃣ IPO size: ₹ 525 cr (QIB+HNI: 90%)
#⃣ Profitable e-com
#⃣ Financials 👇
7. Go Air (Go First)✈️
#⃣ Fast growing ultra-low-cost carrier (ULCC)
#⃣ Gained domestic market share from 8.8% in FY18 to 10.8% in FY20
#⃣ Lower cost structure than IndiGo
#⃣ 50 routes out of 157 are profitable
#⃣ Promoter: Wadia family
#⃣ IPO size: ₹ 3,600 cr
#⃣ Financials 👇
#⃣ India's largest online platform for insurance & lending products (Bank bazaar)
#⃣ Asset light aggregator model (match-making)
#⃣ 50% market share in Term Life processing
#⃣ Entering offline insurance
#⃣ IPO size: ₹ 6,017 cr (Fresh issue: 65%)
#⃣ Financials👇
10. Fino Payments Bank
#⃣ Rural-focussed payments bank
#⃣ Segments: MicroATM, AEPS, DBT/ Remittances, CASA opening
#⃣ Asset light (does not lend)
#⃣ Revenue: Commissions of 0.5-1% per Trsn.
#⃣ FY21 Trsn.: 10.4 cr on AEPS - (121% you)
#⃣ IPO size: ₹ 300 cr
#⃣ Financials👇
11. Adani Wilmar 🧂
#⃣ FMCG w. focus on kitchen commodities - edible oil, wheat flour, rice, pulses & sugar
#⃣ One of the fastest growing packaged food companies
#⃣ Other segments: Personal care, Oleochemicals
#⃣ Promoter: Adani Group
#⃣ IPO size: ₹ 4,500 cr
#⃣ Financials👇
12. Waaree Energies ☀️
#⃣ Key player in solar energy industry focused on PV module manufacturing
#⃣ Installed capacity of 2 GW
#⃣ Industry: Renewable capacity up from 31.6 GW in FY14 to 140 GW in FY21
#⃣ Has 3 mfg. facilities in Gujarat
#⃣ IPO size: ₹ 1,350 cr
#⃣ Financials👇
13. Fincare Small Finance Bank
#⃣ Digital-focused SFB: MFI and SME loans
#⃣ Highest growth rate in advances in peers
(AUM CAGR of 30% b/w FY17 to FY20)
#⃣ Industry consolidation w. top 6 players
#⃣ CASA: 24%; CAR: 29.6%
#⃣ NPAs are high
#⃣ IPO size: ₹ 1,350 cr
#⃣ Financials👇
14. OYO (Oravel Stays)
#⃣ Leading budget stay and hospitality player
#⃣ Focused on reshaping short-stay accommodation
#⃣ Post Covid, count of hotel rooms on its network has declined by >50% around 530,000
#⃣ IPO size: ₹ 8,430 Cr (fresh issue: ₹ 7,000 cr)
#⃣ Financials 👇
15. Paytm
#⃣ India’s leading payments co. with 34 cr customers & over 2.1 cr merchants
#⃣ Business segments: Payment wallets, Payments Bank, Paytm Mall, Paytm Money, Paytm Insurance, E-com, etc
#⃣ Largest investment by Warren Buffet in India
#⃣ IPO: ₹ 16,600 cr
#⃣ Financials
Note: Thread in progress. Balance IPOs list to be added by tomorrow.
We know these are only prelim info. Please ask your questions, share links or put your thoughts on individual names for a more detailed and fruitful discussion :)
16. Global Health Ltd
#⃣ Amongst the top multi-specialty hospitals under ‘Medanta’ brand in Delhi & Lucknow
#⃣ 4 hospitals w. ~2,600 beds (1,250 in Delhi NCR)
#⃣ Specializes in Cardiology, Neurosciences, Oncology, Ortho, liver transplant, Urology
#⃣ Issue: 500crs
#⃣ Financials
17. Veeda Clinical Research
#⃣ Leading clinical research organization
#⃣ Partnered with pharma cos. for providing solutions like bioequivalence studies and pre-clinical trials across North America, Europe & Asia
#⃣ Issue: ~700 crs (Fresh - 331)
#⃣ Leading medical devices co. focused on vascular devices & stents
#⃣ Increasing market share in India (21% --> 31%); strong in Europe region
#⃣ Only listed player in this space is Poly Medicare
#⃣ Issue: Rs 1500 crs (Fresh: 410crs)
#⃣ Low margins
19. Sterlite Power Transmission
#⃣ 2 segments: 1. Infrastructure: Operate power transmission assets in India & Brazil 2. Solutions: Manufactures sub-parts like power conductors, optical ground wires
#⃣ Benefits from 100% rural electrification focus
#⃣Issue:1250 crs
#⃣Financials
20. Vedant Fashion (Manyavar)
#⃣ Largest Men-Branded ethnic wear player in India in terms of revenue & profits
#⃣ Wedding wear market exp. growth at 15%-17%
#⃣ Multi-brands under 'Manyavar'; multi-channel
#⃣ Multiple celebrity brand ambassadors
#⃣ IPO size: NA
#⃣ Financials:
21 C.E. Info System (MapmyIndia)
#⃣ Leading mapping, data, IOT & geospatial company
#⃣ Built detailed digital maps of 7.5L Indian villages & 7,500+ cities
#⃣ Partnered with ISRO recently for satellite imagery
#⃣Industries catered: BFSI, telecom, FMCG, logistics etc
#⃣Financials
22. MobiKwik Systems
#⃣ Key player in Indian Payments focused on: 1. Mobile wallets: Retail/SME focus; high competition 2. Buy Now pay later: fast growing segment, key growth driver
#⃣ 10 cr+ customers
#⃣ Processed payments over $1.6 BN in FY21
#⃣ Issue: 1900crs (fresh-1500cr)
23. Tracxn
#⃣ Leading global intelligence (SaaS) platform on start-ups/ emerging tech
#⃣ Has coverage of over 14 lakh companies across 300 Technology sub-segments & over 30 countries
#⃣ 70% revenues from outside India
Check out podcast with the founders
24. Jana Small Finance Bank
#⃣One of top 4 SFBs
#⃣Unsecured loans: ~70% of the loan book focused on MSMEs, affordable housing & gold loans
#⃣ NBFC-MFI with a focus on low-income states
#⃣ B/w FY17-20, it grew 68% CAGR (2nd highest)
#⃣Key metrics: 1. Till FY20, GNPA was 0, in FY21- spiked to ~11% 2. Comfortable PCR 3. CAR (FY21): 24.3% v/s. 24.8% in FY20
#⃣Issue: 850cr
#⃣Financials
26. Wellness Forever Medicare
#⃣ India’s 3rd largest omnichannel retail pharmacy
#⃣ Hybrid model of medicines & FMCG products
#⃣ Products: 1. FMCG & health 2. Nutraceuticals & Medical Equipments 3. OTC & prescription
#⃣ Issue:400crs
#⃣ Risk: E-pharmacy growth
#⃣ Financials
27. Medplus Health Services
#⃣ 2nd largest pharmacy retailer in India (# of stores & revenue)
#⃣ First pharmacy in India to do omnichannel sales
#⃣ As per Technopak, modern pharmacy retail segment est. grow at 27% CAGR
#⃣ Risk: E-pharmacy growth
#⃣ IPO: 1,639 cr
#⃣ Financials
28. LE Travenues Technology (Ixigo)
#⃣ India’s 2nd largest OTA in terms of operating revenue & gross bookings
#⃣ Flight & rail tickets, hotels, cabs etc
#⃣ 3x growth in op. revenue between FY19 & FY21
#⃣ Industry seeing consolidation
#⃣ Issue: 1600crs (Fresh+OFS)
#⃣ Financials
29. Fusion Micro Finance
#⃣ MFI with focus on low-income, low penetration states (<5 MFIs)
#⃣ Key states: Bihar, UP & Odisha
#⃣ B/w FY18-21, it grew 44% CAGR (3rd highest)
#⃣ Metrics:
AUM: ~4,800 cr
GNPA (FY21): 2.8% (FY20: 1.1%)
CAR (FY21): 35%
#⃣ Issue: 600cr
#⃣ Financials:
If you have come this far and found this helpful, please subscribe for our weekly update at multipie.co
You will also get added to our app waitlist.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
We looked at every company with promoter buying for the period from April 1st to June 30th (Q1 FY23).
A thread.
Please like and retweet to help more investors
1/n Total 178 names - Part 1 of top 64 here 👇
2/n
Total 178 names - Part 2 of top 64 buying here 👇
Note: Top promoter selling at the end of the thread
3/n Sectors that saw the highest level of promoter buying: 1. Cements (mainly) and metals 2. Chemicals and API 3. Auto and auto components 4. Capital Goods 5. Financials
As Philip Fisher said: Getting a reality check directly from people associated with co. gives us "much deeper" insights☝️v/s just reading reports & financials
Russia controls ~17% of Nickel’s total supply & obviously with that amount of supply going out of system, one would assume prices to rise
But someone expected prices to fall!
A🧵on how the 2.3x surge in Nickel prices was triggered by a short trade & not due to supply crunch
What happened exactly?
A Chinese tycoon "Xiang Guangda" who owns the Tsingshan Group, the largest nickel mining group in China had placed huge short bets on London Metal Exchange (LME), expecting the nickel prices would fall.
We wonder why he held that view👀
1/n
This bet went horribly wrong when Russia banned commodity exports & Nickel prices started surging
To cover a big short position, someone had to buy equivalent long positions.
This created a short squeeze & Nickel reached $1lakh/ton & inturn led to notional loss of $8 Bn+!😱 2/n